跳至主要内容
临床试验/NL-OMON49987
NL-OMON49987撤回不适用

Influence of COVID-19 on immune responses to pneumococcal Polysaccharide and influenza vaccinations in older persons - COVID-19 influence on pneumococcal vaccine responsiveness in elderly

RIVM0 个研究点目标入组 600 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
发起方
入组人数
600

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • -Born between 1941-1947 (73-79 years of age)
  • -COVID-19 group: Having had a proven (SARS-CoV-2 PCR test positive) COVID-19
  • infection at least 1 month before study entry
  • -Control group: Have not had a positive SARS-CoV-2 PCR test
  • -Willing to receive the PPV23 vaccine
  • -Be capacitated
  • -Have signed Informed Consent

排除标准

  • -Having had a previous pneumococcal vaccination (PCV or the 23-valent
  • pneumococcal polysaccharide vaccine (PPV23)).

研究者

发起方
RIVM

相似试验